SimBioSys

Chicago, IL · Founded 2017 · Privately Held (backing)

Developer of a medical platform intended to deploy computational oncology to transform decision-making and patient experience in cancer care. SimBioSys is based in Chicago, IL and was founded in 2017. Its last reported valuation was $39 million in Jul 2021. It has raised $21.1 million across 2 recorded rounds; the latest was a $5.2 million early-stage round in Dec 2024.

Last reported valuation
$39.0M
Oct 2026
Priced at
—
Total raised
$21.1M
Last round
Early Stage VC
Dec 2024
How much has SimBioSys raised?
$21.1Macross 2 recorded rounds · Nov 2018 – Dec 2024

Most recently, SimBioSys raised $5.2M in its Early Stage VC (Dec 2024).

Free account
More of SimBioSys with a free account
  • ·The complete investor list: 11 names
  • ·Watch SimBioSys: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

SimBioSys round by round

2 rounds
Dec 2024Early Stage VC$5.2MSEC filing▮
13 investors participated
Nov 2018Debt$900KSEC filing▮
3 investors participated

How much has SimBioSys raised?

SimBioSys has raised $21.1 million in total; 2 of its rounds are on record. The largest on record was a $900,000 debt round in Nov 2018; the most recent was a $5.2 million early-stage round in Dec 2024.

SimBioSys has filed 2 Form Ds with the SEC since 2018, most recently in Jan 2025 ($5.2 million sold to 13 investors).

SimBioSys investors

11 investors are on record for SimBioSys, including Mayo Clinic, Fox Ventures, Genoa Ventures and AV8 Ventures. The early-stage round in Dec 2024 drew 13 investors.

For fundraisers
Raising for a company like SimBioSys?

11 investors have backed SimBioSys.

See all 11 investors →

Frequently asked about SimBioSys

How much has SimBioSys raised?
SimBioSys has raised $21.1M in total across 2 recorded funding rounds.
When was SimBioSys's last funding round?
SimBioSys's most recent recorded round was Early Stage VC in Dec 2024, raising $5.2M.